Helsinki, Finland, March 10, 2010 --(PR.com
)-- Icare Finland is donating its new self-tonometer Icare® ONE to Glaucoma Patient Associations around the world in honour of World Glaucoma Week.
Icare® ONE tonometer is designed for self measuring of intraocular pressure (IOP) by glaucoma patients who constantly need to monitor their IOP (=intraocular pressure). The self-tonometer Icare® ONE revolutionaries IOP control and makes early detection and control of glaucoma more effective.
Icare® ONE improves glaucoma patient’s quality of life and care by making self-measuring of eye pressure possible anywhere and anytime. Icare® ONE is extremely easy to use and patient friendly; gentle measuring requires no anaesthesia drops and no unpleasant air puff is used. Icare® rebound measuring technology is proven to be safe and accurate.
Icare® tonometers are based on unique patented rebound technology and the new Icare® ONE self-tonometry unit brings this technology to everyday use for glaucoma patients.
Be aware of the glaucoma risks.
Glaucoma is one of the leading causes of blindness in people over the age of 40.
There are over 80 million people diagnosed with glaucoma and at least same amount is undiagnosed.
Consult your Ophthalmologist about your personal risks of glaucoma.
Icare Finland Oy is an advanced medical technology company based in Helsinki Finland. We provide tonometers, specialized instruments for measuring Intra Ocular Pressure (IOP) with unique, patented rebound technology.
Icare Finland is a part of Revenio Group Corporation (ex Done Solutions), a public company listed on the Helsinki Stock Exchange.
More information about the Icare ONE campaign from our web-site: www.icaretonometer.com